Marina Arenas, Julia Martín, Juan Luis Santos, Irene Aparicio, Esteban Alonso
{"title":"全自动在线SPE-LC-MS/MS法测定废水中手性β阻断剂和抗抑郁药的对映选择性","authors":"Marina Arenas, Julia Martín, Juan Luis Santos, Irene Aparicio, Esteban Alonso","doi":"10.1016/j.aca.2025.344152","DOIUrl":null,"url":null,"abstract":"<h3>Background</h3>Pharmacologically active compounds are emerging pollutants of greatest concern because of their continuous release to the aquatic media and potential effects on non-target organisms. Nevertheless, in spite that many pharmaceuticals are chiral compounds which enantiomers may have different environmental behaviour and effects, their enantiomeric determination has been scarcely evaluated. This fact can be explained by the great challenge to overcome when developing an analytical method for the individual determination of compounds with the same physical-chemical properties, as it is the case of enantiomers.<h3>Results</h3>In this work, an automatised method based on online solid phase extraction (SPE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) was optimised and validated for the enantiomeric determination of highly prescribed (β-blockers (atenolol, metoprolol and propranolol), antidepressants (citalopram, fluoxetine, sertraline, duloxetine and venlafaxine) and two of their metabolites in influent and effluent wastewater. Three of them (metoprolol, citalopram and venlafaxine) have been recently included in the European Union Directive 2024/3019 as substances that should be measured in wastewater. Method quantification limits in the range from 0.1 to 50 ng L<sup>-1</sup> for most compounds. Accuracy ranged from 60.8 to 114 % and precision, expressed as relative standard deviation, was lower than 12.5 % for all the compounds. Method application to wastewater samples revealed the presence of the target compounds at concentrations between 1.06 and 1213 ng L<sup>-1</sup> and a preferential degradation of some enantiomers: <em>S</em>-(-)-atenolol, metoprolol-E1, venlafaxine-E1 and O-desmethylvenlafaxine-E1.<h3>Significance and novelty</h3>This method is the first one for online SPE-chiral-LC-MS/MS determination of two therapeutic groups of chiral pharmaceuticals in wastewater. The method allows their automatised enantiomeric determination, including sample treatment, SPE column wash and conditioning, and LC-MS/MS determination, in 40 min with enantioresolution from 0.51 to 1.24. The online SPE method developed provides a fast way to obtain information about chiral compounds in wastewater reducing labour intensity, exposure to organic solvents, analyte loss and plastic waste","PeriodicalId":240,"journal":{"name":"Analytica Chimica Acta","volume":"37 1","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ACA-25-200 Rev Clean version Automatised online SPE-LC-MS/MS method for the enantioselective determination of chiral β-blockers and antidepressants in wastewater\",\"authors\":\"Marina Arenas, Julia Martín, Juan Luis Santos, Irene Aparicio, Esteban Alonso\",\"doi\":\"10.1016/j.aca.2025.344152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3>Background</h3>Pharmacologically active compounds are emerging pollutants of greatest concern because of their continuous release to the aquatic media and potential effects on non-target organisms. Nevertheless, in spite that many pharmaceuticals are chiral compounds which enantiomers may have different environmental behaviour and effects, their enantiomeric determination has been scarcely evaluated. This fact can be explained by the great challenge to overcome when developing an analytical method for the individual determination of compounds with the same physical-chemical properties, as it is the case of enantiomers.<h3>Results</h3>In this work, an automatised method based on online solid phase extraction (SPE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) was optimised and validated for the enantiomeric determination of highly prescribed (β-blockers (atenolol, metoprolol and propranolol), antidepressants (citalopram, fluoxetine, sertraline, duloxetine and venlafaxine) and two of their metabolites in influent and effluent wastewater. Three of them (metoprolol, citalopram and venlafaxine) have been recently included in the European Union Directive 2024/3019 as substances that should be measured in wastewater. Method quantification limits in the range from 0.1 to 50 ng L<sup>-1</sup> for most compounds. Accuracy ranged from 60.8 to 114 % and precision, expressed as relative standard deviation, was lower than 12.5 % for all the compounds. Method application to wastewater samples revealed the presence of the target compounds at concentrations between 1.06 and 1213 ng L<sup>-1</sup> and a preferential degradation of some enantiomers: <em>S</em>-(-)-atenolol, metoprolol-E1, venlafaxine-E1 and O-desmethylvenlafaxine-E1.<h3>Significance and novelty</h3>This method is the first one for online SPE-chiral-LC-MS/MS determination of two therapeutic groups of chiral pharmaceuticals in wastewater. The method allows their automatised enantiomeric determination, including sample treatment, SPE column wash and conditioning, and LC-MS/MS determination, in 40 min with enantioresolution from 0.51 to 1.24. The online SPE method developed provides a fast way to obtain information about chiral compounds in wastewater reducing labour intensity, exposure to organic solvents, analyte loss and plastic waste\",\"PeriodicalId\":240,\"journal\":{\"name\":\"Analytica Chimica Acta\",\"volume\":\"37 1\",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analytica Chimica Acta\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1016/j.aca.2025.344152\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytica Chimica Acta","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1016/j.aca.2025.344152","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
摘要
具有药理活性的化合物是新兴的污染物,由于其在水生介质中的持续释放和对非目标生物的潜在影响而备受关注。然而,尽管许多药物是手性化合物,其对映体可能具有不同的环境行为和作用,但它们的对映体测定几乎没有得到评价。这一事实可以解释为,在开发一种分析方法来单独测定具有相同物理化学性质的化合物时,需要克服的巨大挑战,就像对映体的情况一样。结果建立了基于在线固相萃取(SPE) -液相色谱-串联质谱(LC-MS/MS)的自动化方法,对高处方β受体阻滞剂(阿替洛尔、美托洛尔和心得洛尔)、抗抑郁药(西酞普兰、氟西汀、舍曲林、度洛西汀和文拉法辛)及其两种代谢物的对映体测定进行了优化和验证。其中三种(美托洛尔、西酞普兰和文拉法辛)最近被列入欧盟指令2024/3019,作为应在废水中测量的物质。大多数化合物的定量限在0.1 ~ 50 ng L-1。准确度为60.8% ~ 114%,精密度(以相对标准偏差表示)均低于12.5%。方法应用于废水样品,发现目标化合物的浓度在1.06 ~ 1213 ng L-1之间,并且优先降解一些对映体:S-(-)-阿替洛尔、美托洛尔- e1、文拉法辛- e1和o -去甲基文拉法辛- e1。意义与新颖性本文首次建立了在线测定废水中两组治疗性手性药物的方法。该方法允许在40分钟内自动测定对映体,包括样品处理,SPE柱洗涤和调理,LC-MS/MS测定,对映体分辨率为0.51至1.24。开发的在线SPE方法提供了一种快速获取废水中手性化合物信息的方法,减少了劳动强度,暴露于有机溶剂,分析物损失和塑料废物
ACA-25-200 Rev Clean version Automatised online SPE-LC-MS/MS method for the enantioselective determination of chiral β-blockers and antidepressants in wastewater
Background
Pharmacologically active compounds are emerging pollutants of greatest concern because of their continuous release to the aquatic media and potential effects on non-target organisms. Nevertheless, in spite that many pharmaceuticals are chiral compounds which enantiomers may have different environmental behaviour and effects, their enantiomeric determination has been scarcely evaluated. This fact can be explained by the great challenge to overcome when developing an analytical method for the individual determination of compounds with the same physical-chemical properties, as it is the case of enantiomers.
Results
In this work, an automatised method based on online solid phase extraction (SPE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) was optimised and validated for the enantiomeric determination of highly prescribed (β-blockers (atenolol, metoprolol and propranolol), antidepressants (citalopram, fluoxetine, sertraline, duloxetine and venlafaxine) and two of their metabolites in influent and effluent wastewater. Three of them (metoprolol, citalopram and venlafaxine) have been recently included in the European Union Directive 2024/3019 as substances that should be measured in wastewater. Method quantification limits in the range from 0.1 to 50 ng L-1 for most compounds. Accuracy ranged from 60.8 to 114 % and precision, expressed as relative standard deviation, was lower than 12.5 % for all the compounds. Method application to wastewater samples revealed the presence of the target compounds at concentrations between 1.06 and 1213 ng L-1 and a preferential degradation of some enantiomers: S-(-)-atenolol, metoprolol-E1, venlafaxine-E1 and O-desmethylvenlafaxine-E1.
Significance and novelty
This method is the first one for online SPE-chiral-LC-MS/MS determination of two therapeutic groups of chiral pharmaceuticals in wastewater. The method allows their automatised enantiomeric determination, including sample treatment, SPE column wash and conditioning, and LC-MS/MS determination, in 40 min with enantioresolution from 0.51 to 1.24. The online SPE method developed provides a fast way to obtain information about chiral compounds in wastewater reducing labour intensity, exposure to organic solvents, analyte loss and plastic waste
期刊介绍:
Analytica Chimica Acta has an open access mirror journal Analytica Chimica Acta: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
Analytica Chimica Acta provides a forum for the rapid publication of original research, and critical, comprehensive reviews dealing with all aspects of fundamental and applied modern analytical chemistry. The journal welcomes the submission of research papers which report studies concerning the development of new and significant analytical methodologies. In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and impact of the research and the extent to which it adds to the existing body of knowledge in analytical chemistry.